Emerging roles of cardiolipin remodeling in mitochondrial dysfunction associated with diabetes, obesity, and cardiovascular diseases

Journal of Biomedical Research

Volumn 24, Issue 1, 2010, Pages 6-15

  Shi, Yuguang ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; ACYLTRANSFERASE; ARACHIDONIC ACID; CARDIOLIPIN; CATALASE; DOCOSAHEXAENOIC ACID; HYDROXYL RADICAL; INSULIN; LINOLEIC ACID; NITROGEN OXIDE; PEROXY RADICAL; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROSIGLITAZONE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TAFAZZIN; THYROID HORMONE; THYROXINE; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; APOPTOSIS; BATH SYNDROME; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GENE OVEREXPRESSION; HEART FAILURE; HISTOPATHOLOGY; HUMAN; HYPERTHYROIDISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID COMPOSITION; LIPID PEROXIDATION; LIPIDOMICS; LIPOGENESIS; LIVER MITOCHONDRION; METABOLIC DISORDER; METABOLIC PARAMETERS; MITOCHONDRIAL MEMBRANE; MOLECULAR BIOLOGY; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; RISK FACTOR; X CHROMOSOME LINKED DISORDER;

EID: 78449294221     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1674-8301(10)60003-6     Document Type: Review

References (100)

1. Lowell BB, Shulman GI Mitochondrial dysfunction and type 2 diabetes. Science 2005, 307:384-387.
2. Morino K, Petersen KF, Shulman GI Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006, 55(Suppl 2):S9-S15.
3. Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 2006, 55:2277-2285.
4. Asmann YW, Stump CS, Short KR, Coenen-Schimke JM, Guo Z, Bigelow ML, et al. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 2006, 55:3309-3319.
5. Petersen KF, Dufour S, Shulman GI Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med 2005, 2:e233.
6. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 2003, 100:7996-8001.
7. Mootha VK, Handschin C, Arlow D, Xie X, St Pierre J, Sihag S, et al. Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci USA 2004, 101:6570-6575.
8. Nair KS, Bigelow ML, Asmann YW, Chow LS, Coenen-Schimke JM, Klaus KA, et al. Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 2008, 57:1166-1175.
9. Pospisilik JA, Knauf C, Joza N, Benit P, Orthofer M, Cani PD, et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 2007, 131:476-491.
10. Turner N, Li JY, Gosby A, To SWC, Cheng Z, Miyoshi H, et al. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 2008, 57:1414-1418.
11. Brunmair B, Staniek K, Gras F, Scharf N, Althaym A, Clara R, et al. Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?. Diabetes 2004, 53:1052-1059.
12. Owen MR, Doran E, Halestrap AP Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000, 348(Pt 3):607-614.
13. El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 2000, 275:223-228.
14. Chen S, He Q, Greenberg ML Loss of tafazzin in yeast leads to increased oxidative stress during respiratory growth. Mol Microbiol 2008, 68:1061-1072.
15. Chicco AJ, Sparagna GC Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 2007, 292:C33-C44.
16. Paradies G, Petrosillo G, Paradies V, Ruggiero FM Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease. Cell Calcium 2009, 45:643-650.
17. Schlame M, Rua D, Greenberg ML The biosynthesis and functional role of cardiolipin. Prog Lipid Res 2000, 39:257-288.
18. Xu Y, Kelley RI, Blanck TJJ, Schlame M Remodeling of cardiolipin by phospholipid transacylation. J Biol Chem 2003, 278:51380-51385.
19. Cao J, Liu Y, Lockwood J, Burn P, Shi Y A novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysoCL acyltransferase (ALCAT1) in mouse. J Biol Chem 2004, 279:31727-31734.
20. Taylor WA, Hatch GM Identification of the human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCL AT-1). J Biol Chem 2009, 284:30360-30371.
21. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors.[see comment]. Nat Chem Biol 2005, 1:223-232.
22. Han X, Yang J, Cheng H, Yang K, Abendschein DR, Gross RW Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. Biochemistry 2005, 44:16684-16694.
23. Han X, Yang J, Yang K, Zhao Z, Abendschein DR, Gross RW Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipodomics study. Biochemistry 2007, 46:6417-6428.
24. Sparagna GC, Lesnefsky EJ Cardiolipin remodeling in the heart. J Cardiovasc Pharmacol 2009, 53:290-301.
25. Menshikova EV, Ritov VB, Ferrell RE, Azuma K, Goodpaster BH, Kelley DE Characteristics of skeletal muscle mitochondrial biogenesis induced by moderate-intensity exercise and weight loss in obesity. J Appl Physiol 2007, 103:21-27.
26. Lee HJ, Mayette J, Rapoport SI, Bazinet RP Selective remodeling of cardiolipin fatty acids in the aged rat heart. Lipids Health Dis 2006, 5:2.
27. Orrenius S, Zhivotovsky B, Nicotera P Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003, 4:552-565.
28. Paradies G, Petrosillo G, Pistolese M, Ruggiero FM (2002) Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 2002, 286:135-141.
29. Nomura K, Imai H, Koumura T, Kobayashi T, Nakagawa Y Mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits the release of cytochrome c from mitochondria by suppressing the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis. Biochem J 2000, 351:183-193.
30. Zhong Q, Gohil VM, Ma L, Greenberg ML Absence of cardiolipin results in temperature sensitivity, respiratory defects, and mitochondrial DNA instability independent of pet56. J Biol Chem 2004, 279:32294-32300.
31. Ohtsuka T, Nishijima M, Suzuki K, Akamatsu Y Mitochondrial dysfunction of a cultured Chinese hamster ovary cell mutant deficient in cardiolipin. J Biol Chem 1993, 268:22914-22919.
32. Schlame M, Brody S, Hostetler KY Mitochondrial cardiolipin in diverse eukaryotes. Comparison of biosynthetic reactions and molecular acyl species. Eur J Biochem 1993, 212:727-735.
33. Schlame M, Horvath L, Vigh L Relationship between lipid saturation and lipid-protein interaction in liver mitochondria modified by catalytic hydrogenation with reference to cardiolipin molecular species. Biochem J 1990, 265:79-85.
34. Yamaoka-Koseki S, Urade R, Kito M Cardiolipins from rats fed different dietary lipids affect bovine heart cytochrome c oxidase activity. J Nutr 1991, 121:956-958.
35. Hostetler KY, Galesloot JM, Boer P, Van Den Bosch H Further studies on the formation of cardiolipin and phosphatidylglycerol in rat liver mitochondria. Effect of divalent cations and the fatty acid composition of CDP-diglyceride. Biochim Biophys Acta 1975, 380:382-389.
36. Rustow B, Schlame M, Rabe H, Reichmann G, Kunze D Species pattern of phosphatidic acid, diacylglycerol, CDP-diacylglycerol and phosphatidylglycerol synthesized de novo in rat liver mitochondria. Biochim Biophys Acta 1989, 1002:261-263.
37. Schlame M, Rustow B, Kunze D, Rabe H, Reichmann G Phosphatidylglycerol of rat lung. Intracellular sites of formation de novo and acyl species pattern in mitochondria, microsomes and surfactant. Biochem J 1986, 240:247-252.
38. Chen D, Zhang XY, Shi Y Identification and functional characterization of hCLS1, a human cardiolipin synthase localized in mitochondria. Biochem J 2006, 398:169-176.
39. Houtkooper RH, Akbari H, van Lenthe H, Kulik W, Wanders RJA, Frentzen M, et al. Identification and characterization of human cardiolipin synthase. FEBS Lett 2006, 580:3059-3064.
40. Lu B, Xu FY, Jiang YJ, Choy PC, Hatch GM, Grunfeld C, et al. Cloning and characterization of a cDNA encoding human cardiolipin synthase (hCLS1). J Lipid Res 2006, 47:1140-1145.
41. Nie J, Hao X, Chen D, Han X, Chang Z, Shi Y A novel function of the human CLS1 in phosphatidylglycerol synthesis and remodeling. Biochim Biophys Acta 2009, (E pub ahead of print).
42. Taylor WA, Hatch GM Purification and characterization of monolysocardiolipin acyltransferase from pig liver mitochondria. J Biol Chem 2003, 278:12716-12721.
43. Van Q, Liu J, Lu B, Feingold KR, Shi Y, Lee RM, Hatch GM Phospholipid scramblase-3 regulates cardiolipin de novo biosynthesis and its resynthesis in growing HeLa cells. Biochem J 2007, 401:103-109.
44. Evans JL, Goldfine ID, Maddux BA, Grodsky GM Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endo Rev 2002, 23:599-622.
45. Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Federici A, Ruggiero FM Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and CL. Cir Res 2004, 94:53-59.
46. Pfeiffer K, Gohil V, Stuart RA, Hunte C, Brandt U, Greenberg ML, et al. Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem 2003, 278:52873-52880.
47. Paradies G, Petrosillo G, Pistolese M, Ruggiero FM The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett 2000, 466:323-326.
48. Barth PG, Valianpour F, Bowen VM, Lam J, Duran M, Vaz FM, et al. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update. Am J Med Genet Part A 2004, 126:349-354.
49. Neuwald AF Barth syndrome may be due to an acyltransferase deficiency. Curr Biol 1997, 7:R465-R466.
50. Barth PG, Scholte HR, Berden JA, Van der Klei-Van Moorsel JM, Luyt-Houwen IE, Van 't Veer-Korthof ET, et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 1983, 62:327-355.
51. Vreken P, Valianpour F, Nijtmans LG, Grivell LA, Plecko B, Wanders RJ, et al. Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys Res Commun 2000, 279:378-382.
52. Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, Blanck TJ Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol 2002, 51:634-637.
53. Bissler JJ, Tsoras M, Goring HH, Hug P, Chuck G, Tombragel E, et al. Infantile dilated X-linked cardiomyopathy, G4.5 mutations, altered lipids, and ultrastructural malformations of mitochondria in heart, liver, and skeletal muscle. Lab Invest 2002, 82:335-344.
54. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009, 119:573-581.
55. Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin M-A, Morio B, et al. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 2008, 118:789-800.
56. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114:1752-1761.
57. Houstis N, Rosen ED, Lander ES Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
58. Atabek ME, Vatansev H, Erkul I Oxidative stress in childhood obesity. J Pediatr Endocrinol Metab 2004, 17:1063-1068.
59. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1997, 27:484-490.
60. Maddux BA, See W, Lawrence JC, Goldfine AL, Goldfine ID, Evans JL Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes 2001, 50:404-410.
61. Tirosh A, Potashnik R, Bashan N, Rudich A Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem 1999, 274:10595-10602.
62. Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, et al. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 2004, 53:1336-1343.
63. Watkins SM, Reifsnyder PR, Pan HJ, German JB, Leiter EH Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J Lipid Res 2002, 43:1809-1817.
64. Hong MY, Chapkin RS, Barhoumi R, Burghardt RC, Turner ND, Henderson CE, et al. Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes. Carcinogenesis 2002, 23:1919-1925.
65. Watkins SM, Carter LC, German JB Docosahexaenoic acid accumulates in cardiolipin and enhances HT-29 cell oxidant production. J Lipid Res 1998, 39:1583-1588.
66. Pan HJ, Lin Y, Chen YE, Vance DE, Leiter EH Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism. Vascul Pharmacol 2006, 45:65-71.
67. Yamaoka S, Urade R, Kito M Mitochondrial function in rats is affected by modification of membrane phospholipids with dietary sardine oil. J Nutr 1988, 118:290-296.
68. Asayama K, Kato K Oxidative muscular injury and its relevance to hyperthyroidism. Free Radical Biol Med 1990, 8:293-303.
69. Nishiki K, Erecinska M, Wilson DF, Cooper S Evaluation of oxidative phosphorylation in hearts from euthyroid, hypothyroid, and hyperthyroid rats. Am J Physiol 1978, 235:C212-C219.
70. Venditti P, De Rosa R, Cigliano L, Agnisola C, Di Meo S Role of nitric oxide in the functional response to ischemia-reperfusion of heart mitochondria from hyperthyroid rats. Cell Mol Life Sci 2004, 61:2244-2252.
71. Hatch GM Cell biology of cardiac mitochondrial phospholipids. Biochem Cell Biol 2004, 82:99-112.
72. Gredilla R, Lopez Torres M, Portero-Otin M, Pamplona R, Barja G Influence of hyper- and hypothyroidism on lipid peroxidation, unsaturation of phospholipids, glutathione system and oxidative damage to nuclear and mitochondrial DNA in mice skeletal muscle. Mol Cell Biochem 2001, 221:41-48.
73. Cao SG, Cheng P, Angel A, Hatch GM Thyroxine stimulates phosphatidylglycerolphosphate synthase activity in rat heart mitochondria. Biochim Biophys Acta 1995, 1256:241-244.
74. Hostetler KY Effect of thyroxine on the activity of mitochondrial cardiolipin synthase in rat liver. Biochim Biophys Acta 1991, 1086:139-140.
75. Mutter T, Dolinsky VW, Ma BJ, Taylor WA, Hatch GM Thyroxine regulation of monolysocardiolipin acyltransferase activity in rat heart. Biochem J 2000, 345(Pt 2):403-406.
76. Taylor WA, Xu FY, Ma BJ, Mutter TC, Dolinsky VW, Hatch GM Expression of monolysoCL acyltransferase activity is regulated in concert with the level of cardiolipin and cardiolipin biosynthesis in the mammalian heart. BMC Biochem 2002, 3:9.
77. Venditti P, Di Meo S Thyroid hormone-induced oxidative stress. Cell Mol Life Sci 2006, 63:414-434.
78. Cao J, Shen W, Chang Z, Shi Y ALCAT1 is a polyglycerophospholipid acyltransferase potently regulated by adenine nucleotide and thyroid status. Am J Physiol Endocrinol Metab 2009, 296:E647-E653.
79. Turrens JF Mitochondrial formation of reactive oxygen species. J Physiol 2003, 552:335-344.
80. Papa S, Skulachev VP Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 1997, 174:305-319.
81. Paradies G, Petrosillo G, Pistolese M, Ruggiero FM Reactive oxygen species generated by the mitochondrial respiratory chain affect the complex III activity via cardiolipin peroxidation in beef-heart submitochondrial particles. Mitochondrion 2001, 1:151-159.
82. Petrosillo G, Ruggiero FM, Di Venosa N, Paradies G Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin. FASEB J 2003, 17:714-716.
83. Pierangeli SS, Harris EN Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Lupus 2003, 12:539-545.
84. Sparagna GC, Chicco AJ, Murphy RC, Bristow MR, Johnson CA, Rees ML, et al. Loss of cardiac tetralinoleoyl cardiopilin in human and experimental heart failure. J Lipid Res 2007, 48:1559-1570.
85. Shigenaga MK, Hagen TM, Ames BN Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 1994, 91:10771-10778.
86. Wallace DC A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005, 39:359-407.
87. Pamplona R, Portero-Otin M, Riba D, Ruiz C, Prat J, Bellmunt MJ, et al. Mitochondrial membrane peroxidizability index is inversely related to maximum life span in mammals. J Lipid Res 1998, 39:1989-1994.
88. Hulbert AJ The links between membrane composition, metabolic rate and lifespan. Comp Biochem Physiol A Mol Integr Physiol 2008, 150:196-203.
89. Wright AF, Jacobson SG, Cideciyan AV, Roman AJ, Shu X, Vlachantoni D, et al. Lifespan and mitochondrial control of neurodegeneration. Nat Genet 2004, 36:1153-1158.
90. Paradies G, Ruggiero FM Effect of aging on the activity of the phosphate carrier and on the lipid composition in rat liver mitochondria. Arch Biochem Biophy 1991, 284:332-337.
91. Paradies G, Ruggiero FM, Gadaleta MN, Quagliariello E The effect of aging and acetyl-L-carnitine on the activity of the phosphate carrier and on the phospholipid composition in rat heart mitochondria. Bioch Biophy Acta 1992, 1103:324-326.
92. Paradies G, Ruggiero FM, Petrosillo G, Gadaleta MN, Quagliariello E Effect of aging and acetyl-L-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria. FEBS Lett 1994, 350:213-215.
93. Paradies G, Ruggiero FM, Petrosillo G, Quagliariello E Age-dependent decline in the cytochrome c oxidase activity in rat heart mitochondria: role of cardiolipin. FEBS Lett 1997, 406:136-138.
94. Paradies G, Petrosillo G, Gadaleta MN, Ruggiero FM The effect of aging and acetyl-L-carnitine on the pyruvate transport and oxidation in rat heart mitochondria. FEBS Lett 1999, 454:207-209.
95. Pope S, Land JM, Heales SJ Oxidative stress and mitochondrial dysfunction in neurodegeneration; Cardiolipin a critical target?. Biochim Biophys Acta 2008, 1777:794-799.
96. Ruggiero FM, Cafagna F, Petruzzella V, Gadaleta MN, Quagliariello E Lipid composition in synaptic and nonsynaptic mitochondria from rat brains and effect of aging. J Neurochem 1992, 59:487-491.
97. Sen T, Sen N, Tripathi G, Chatterjee U, Chakrabarti S Lipid peroxidation associated cardiolipin loss and membrane depolarization in rat brain mitochondria. Neurochem Int 2006, 49:20-27.
98. Kiebish MA, Han X, Cheng H, Chuang JH, Seyfried TN Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res 2008, 49:2545-2556.
99. Ellis CE, Murphy EJ, Mitchell DC, Golovko MY, Scaglia F, Barcelo-Coblijn GC, et al. Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synuclein. Mol Cell Biol 2005, 25:10190-10201.
100. Bayir H, Tyurin VA, Tyurina YY, Viner R, Ritov VB, Amoscato AA, et al. Selective early cardiolipin peroxidation after traumatic brain injury: an oxidative lipidomics analysis. Ann Neurol 2007, 62:154-169.